Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia

Shock

Volumn 9, Issue 2, 1998, Pages 109-115

  Sætre, Torunn ^a,d   Gundersen, Yngvar ^a   Thiemermann, Cristoph ^b   Lilleaasen, Per ^c   Aasen, Ansgar O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOETHYLISOTHIOURONIUM; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; OXYGEN; THIOUREA;

ANIMAL; ARTICLE; BLOOD GAS ANALYSIS; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENDOTOXEMIA; HEMODYNAMICS; LIVER CIRCULATION; METABOLISM; SWINE;

ANIMALS; BETA-AMINOETHYL ISOTHIOUREA; BLOOD GAS ANALYSIS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; HEMODYNAMIC PROCESSES; LIPOPOLYSACCHARIDES; LIVER CIRCULATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; SWINE; THIOUREA;

EID: 0031989243     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199802000-00006     Document Type: Article

References (35)

1. Thiemermann C: The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.
2. Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase in septic shock. Prog Clin Biol Res 392:383-392, 1995.
3. MacMicking JD, Nathan C, Horn G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in 1995 Cell 81:1170]. Cell 81:641-650, 1995.
4. Southan GJ, Szabo C, Thiemermann C: Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510-516, 1995.
5. Ruetten H, Thiemermann C: Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem Biophys Res Commun 225:525-530, 1996.
6. G-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48:565-569, 1990.
7. Meyer J, Traber LD, Nelson S, et al: Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73:324-328, 1992.
8. Sætre T, Smiseth OA, Scholz T, et al: Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am J Physiol 271:H1325-H1332, 1996.
9. Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R: Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol 114: 363-368, 1995.
10. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
11. Misko TP, Moore WM, Kasten TP, et al: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-125, 1993.
12. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
13. Thiemermann C, Ruetten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851, 1995.
14. Fink MP, Fiallo V, Stein KL, Gardiner WM: Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: Development of a new model of the clinical syndrome of hyperdynamic sepsis. Circ Shock 22:73-81, 1987.
15. Parrillo JE: Pathogenetic mechanisms of septic shock [see comments]. N Engl J Med 328:1471-1477, 1993.
16. 2 uptake during endotoxemia. J Appl Physiol 64:2410-2419, 1988.
17. Chittock DR, Russell JA: Oxygen delivery and consumption during sepsis. Clin Chest Med 17:263-278, 1996.
18. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992.
19. G-monomefhyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178:1135-1140, 1991.
20. 2 extraction during endotoxemia. Role of nitric oxide synthesis. Am J Respir Crit Care Med 151:107-115, 1995.
21. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 75:1086-1095, 1994.
22. Zhang H, Nguyen DN, Spapen H, Moock M, Maciel F, Vincent JL: Sodium nitroprusside does not influence tissue oxygen extraction capabilities during a critical reduction in oxygen delivery. Cardiovasc Res 30:240-245, 1995.
23. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL: Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 260:C910-C916, 1991.
24. Szabo C, Zingarelli B, Salzman AL: Role of poly ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78: 1051-1063, 1996.
25. Hotchkiss RS, Karl IE: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. J Am Med Assoc 267:1503-1510, 1992.
26. McCuskey RS, Reilly FD: Hepatic microvasculature: Dynamic structure and its regulation. Semin Liver Dis 13:1-12, 1993.
27. Nishida J, McCuskey RS, McDonnell D, Fox ES: Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267:G1135-G1141, 1994.
28. Parker JL, Myers PR, Zhong Q, Kim K, Adams HR: Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 2:451-458, 1994.
29. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabo C: Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117:619-632, 1996.
30. Meyer J, Lentz CW, Stothert JC Jr, Traber LD, Herndon DN, Traber DL: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22:306-312, 1994.
31. Fink MP: Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 21(Suppl):S4-S8, 1993.
32. Gundersen Y, Sætre T, Scholz T, Carlsen H, Kjekshus H, Smiseth AO: The NO donor sodium nitroprusside reverses the negative effect on hepatic arterial flow induced by endotoxin and the NO synthase inhibitor L-NAME. Eur Surg Res 28:323-332, 1996.
33. Morris SM Jr, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829-E839, 1994.
34. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
35. Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabo C: Peroxynitrite-mediated DNA strand breakage activates poly adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156:350-358, 1996.